Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Exp Eye Res. 2008 Nov 1;88(3):418–425. doi: 10.1016/j.exer.2008.10.010

Fig. 4.

Fig. 4

Representative MR images after intravitreal injection of (a) 0.25, (b) 1, and (c) 4 mg/ml Galbumin™ in vivo. From left to right: (a) at 20 min, 4 h, 7 h, 12 h, and 22 h, (b) at 20 min, 4 h, 13 h, 23.5 h, 39.5 h, and 58.5 h and (c) at 20 min, 4 h, 13 h, 23.5 h, 39.5 h, and 58.5 h, respectively.